Amylyx’s ALS Treatment Relyvrio Beats Expectations Again

Expanding Studies Into Other Conditions

 
• By Andrew McConaghie
  
Wheelchair
Relyvrio aims to slow the progress of the muscle-wasting condition, which leaves patients unable to walk. • Source: Shutterstock

More from Neurological

More from Therapy Areas